LogicBio Therapeutics Inc. (LOGC) NASDAQ

$0.42 -0.01 (-1.74%)

Market Cap: $13.76M

As of 05/18/22 04:00 PM EDT. Market closed.

(LOGC)

LogicBio Therapeutics Inc. (LOGC) NASDAQ

$0.42 -0.01 (-1.74%)

Market Cap: $13.76M

As of 05/18/22 04:00 PM EDT. Market closed.

LogicBio Therapeutics is a clinical-stage genetic medicine company pioneering gene delivery and gene editing platforms to address rare and serious diseases from infancy through adulthood. The company's proprietary GeneRide™ platform is a new approach to precise gene insertion that harnesses a cell's natural DNA repair process leading to durable therapeutic protein expression levels. LogicBio's ... read more

LogicBio Therapeutics is a clinical-stage genetic medicine company pioneering gene delivery and gene editing platforms to address rare and serious diseases from infancy through adulthood. The company's proprietary GeneRide™ platform is a new approach to precise gene insertion that harnesses a cell's natural DNA repair process leading to durable therapeutic protein expression levels. LogicBio's cutting-edge sAAVy™ capsid development platform is designed to support development of treatments in a broad range of indications and tissues. The company is based in Lexington, MA. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
CEO
Frederic Chereau
Full Time Employees
39
CEO Compensation (Base)
$411,407
CEO Compensation (Total)
$1.60M
URL
Address
65 Hayden Ave, 2Nd Floor, Massachusetts, Lexington, 02421.
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
CEO
Frederic Chereau
Full Time Employees
39
CEO Compensation (Base)
$411,407
CEO Compensation (Total)
$1.60M
Address
65 Hayden Ave, 2Nd Floor, Massachusetts, Lexington, 02421.
PRICE CHART
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
KEY STATS
Open
$0
Previous Close
$0.42
Days Range
$0.40 - $0.43
52 week range
$0.34 - $5.19
Volume
0
Avg. Volume (30 days)
3,554,958
Market Cap
$13.76M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
32,962,733
Open
$0
Previous Close
$0.42
Days Range
$0.40 - $0.43
52 week range
$0.34 - $5.19
Volume
0
Avg. Volume (30 days)
3,554,958
Market Cap
$13.76M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
32,962,733

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR LOGICBIO THERAPEUTICS INC
Owner Relationship Date Transaction Cost # Shares Value($) Total Shares Form 4
Jones Cecilia Chief Financial Officer Jan 12, 2022 Option Exercise $2.01 2,175 4,372 3,764 Jan 13, 2022, 06:36 PM
Gruskin Daniel Chief Medical Officer Aug 09, 2021 Sale $4.35 1,467 6,381 3,331 Aug 10, 2021, 06:31 PM
Chereau Frederic President and Chief Executive Apr 16, 2021 Sale $5.73 7,542 43,216 253,811 Apr 19, 2021, 09:00 PM
ORBIMED ADVISORS LLC Director Oct 01, 2020 Buy $6.00 1,481,482 8,888,892 4,126,972 Oct 05, 2020, 05:36 PM
Chimovits Erez Director Oct 01, 2020 Buy $6.00 1,481,482 8,888,892 4,126,972 Oct 05, 2020, 05:32 PM
Arix Bioscience plc 10% Owner Jul 16, 2020 Sale $8.56 16,332 139,786 2,962,691 Oct 05, 2020, 05:00 PM
Arix Bioscience plc 10% Owner Aug 12, 2020 Sale $8.79 1,335 11,735 2,867,912 Oct 05, 2020, 05:00 PM
Arix Bioscience plc 10% Owner Jul 29, 2020 Sale $8.78 2,709 23,788 2,869,247 Oct 05, 2020, 05:00 PM
Arix Bioscience plc 10% Owner Sep 28, 2020 Sale $7.54 273,584 2,061,866 2,381,436 Oct 05, 2020, 05:00 PM
Arix Bioscience plc 10% Owner Jul 22, 2020 Sale $9.00 22,651 203,950 2,871,956 Oct 05, 2020, 05:00 PM
Arix Bioscience plc 10% Owner Sep 25, 2020 Sale $7.08 174,219 1,232,948 2,655,020 Oct 05, 2020, 05:00 PM
Arix Bioscience plc 10% Owner Jul 20, 2020 Sale $9.25 36,983 342,056 2,894,607 Oct 05, 2020, 05:00 PM
Arix Bioscience plc 10% Owner Sep 24, 2020 Sale $7.63 38,514 293,823 2,829,239 Oct 05, 2020, 05:00 PM
Arix Bioscience plc 10% Owner Jul 17, 2020 Sale $9.24 31,101 287,373 2,931,590 Oct 05, 2020, 05:00 PM
Arix Bioscience plc 10% Owner Aug 13, 2020 Sale $8.75 159 1,391 2,867,753 Oct 05, 2020, 05:00 PM
Wilton Thomas Chief Business Officer Aug 27, 2019 Option Exercise $0.73 75,000 54,750 75,000 Aug 29, 2019, 04:15 PM
Arix Bioscience plc 10% Owner Oct 23, 2018 Buy $10.00 700,000 7,000,000 2,979,023 Oct 26, 2018, 09:29 AM
ORBIMED ADVISORS LLC Director Oct 23, 2018 Buy $10.00 1,190,000 11,900,000 6,466,783 Oct 25, 2018, 06:28 PM
Kariv Tomer Director Oct 23, 2018 Buy $10.00 420,000 4,200,000 1,787,413 Oct 25, 2018, 06:27 PM
Ioannidou Sofia Director Oct 23, 2018 Buy $10.00 420,000 4,200,000 1,787,413 Oct 25, 2018, 06:25 PM
O'Connell Daniel P Director Oct 23, 2018 Buy $10.00 700,000 7,000,000 2,979,023 Oct 25, 2018, 06:25 PM
Chimovits Erez Director Oct 23, 2018 Buy $10.00 490,000 4,900,000 3,487,760 Oct 25, 2018, 06:24 PM
Load More Insider Transactions
Buy Sale Option Exercise
Owner Relationship Date Value($)
Jones Cecilia Chief Financial Officer 01/12/2022 4,372
Gruskin Daniel Chief Medical Officer 08/09/2021 6,381
Chereau Frederic President and Chief Executive 04/16/2021 43,216
ORBIMED ADVISORS LLC Director 10/01/2020 8,888,892
Chimovits Erez Director 10/01/2020 8,888,892
Arix Bioscience plc 10% Owner 07/16/2020 139,786
Arix Bioscience plc 10% Owner 08/12/2020 11,735
Arix Bioscience plc 10% Owner 07/29/2020 23,788
Arix Bioscience plc 10% Owner 09/28/2020 2,061,866
Arix Bioscience plc 10% Owner 07/22/2020 203,950
Arix Bioscience plc 10% Owner 09/25/2020 1,232,948
Arix Bioscience plc 10% Owner 07/20/2020 342,056
Arix Bioscience plc 10% Owner 09/24/2020 293,823
Arix Bioscience plc 10% Owner 07/17/2020 287,373
Arix Bioscience plc 10% Owner 08/13/2020 1,391
Wilton Thomas Chief Business Officer 08/27/2019 54,750
Arix Bioscience plc 10% Owner 10/23/2018 7,000,000
ORBIMED ADVISORS LLC Director 10/23/2018 11,900,000
Kariv Tomer Director 10/23/2018 4,200,000
Ioannidou Sofia Director 10/23/2018 4,200,000
O'Connell Daniel P Director 10/23/2018 7,000,000
Chimovits Erez Director 10/23/2018 4,900,000
Load More Insider Transactions